MRNA Jun 2024 230.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

88.07

0.00

(0.00%)

As of 11:57AM EDT. Market open.

Loading interactive chart…

Zacks
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Simply Wall St.
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO Compensation Package
Key Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total compensation includes...
Zacks
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Investors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.